LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Nasdaq:LIXT

Pharmaceutical Preparations·BOCA RATON, FL

CEO

Pursglove Geordan Garrett

CFO

Stazzone Peter

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K	FY 2024	12/31/24	3/24/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

News (8-K)

80 shown

Filed	Type	Description
3/10/26	Agreement	Entry into a Material Definitive Agreement	→
2/18/26	Agreement	Entry into a Material Definitive Agreement	→
12/31/25	Agreement	Entry into a Material Definitive Agreement	→
12/23/25	Agreement	Entry into a Material Definitive Agreement	→
12/22/25	Agreement	Entry into a Material Definitive Agreement	→
12/11/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

32 shown

Filed	Form	Description
12/19/25	424B5	424B5	→
7/10/25	S-1/A	S-1/A	→
7/8/25	424B5	424B5	→
6/24/25	S-1/A	S-1/A	→
6/18/25	S-1	S-1	→
4/11/25	424B4	424B4	→
↓

Filing History(492 filings)

TypeDateAccessionPeriodSize

8-K

Mar 10, 2026

0001493152-26-0095268-K

Mar 6, 2026

521.8 KB

8-K

Feb 18, 2026

0001493152-26-0072688-K

Feb 12, 2026

5.0 MB

8-K

Dec 31, 2025

0001493152-25-0297788-K

Dec 30, 2025

342.7 KB

Dec 29, 2025

0001493152-25-0294604

Dec 24, 2025

5.6 KB

Dec 29, 2025

0001493152-25-0294594

Dec 24, 2025

5.6 KB

8-K

Dec 23, 2025

0001493152-25-0289998-K

Dec 17, 2025

9.6 MB

8-K

Dec 22, 2025

0001493152-25-0288508-K

Dec 16, 2025

1.1 MB

424B5

Dec 19, 2025

0001493152-25-028431424B5

—

1.1 MB

8-K

Dec 11, 2025

0001493152-25-0272198-K

Dec 8, 2025

215.4 KB

25-NSE/A

Nov 28, 2025

0001354457-25-001190

—

3.0 KB

8-K

Nov 25, 2025

0001493152-25-0249968-K

Nov 25, 2025

766.9 KB

10-Q

Nov 12, 2025

0001493152-25-02194110-Q

Sep 30, 2025

9.8 MB

DEFA14A

Oct 28, 2025

0001493152-25-019890DEFA14A

—

1.1 MB

DEF 14A

Oct 27, 2025

0001493152-25-019697DEF 14A

Oct 27, 2025

3.1 MB

PRE 14A

Oct 16, 2025

0001493152-25-018343PRE 14A

Oct 16, 2025

3.3 MB

8-K

Sep 11, 2025

0001641172-25-0271098-K

Sep 11, 2025

265.6 KB

Sep 10, 2025

0001493152-25-012977

Sep 1, 2025

2.9 KB

Sep 4, 2025

0001641172-25-026560

Sep 1, 2025

5.7 KB

Sep 4, 2025

0001641172-25-026552

Sep 1, 2025

2.9 KB

Sep 4, 2025

0001641172-25-026551

Sep 1, 2025

2.9 KB

8-K

Sep 4, 2025

0001641172-25-0264488-K

Sep 3, 2025

276.4 KB

8-K

Aug 19, 2025

0001641172-25-0246808-K

Aug 18, 2025

276.5 KB

Aug 18, 2025

0001641172-25-0245874

Aug 15, 2025

5.8 KB

Aug 18, 2025

0001641172-25-0245754

Aug 15, 2025

5.7 KB

8-K

Aug 14, 2025

0001641172-25-0236288-K

Aug 13, 2025

271.1 KB

25 filings shown

Filed	Form	Description
11/28/25	25-NSE/A	25-NSE/A	→
7/15/25	EFFECT	EFFECT	→
5/2/25	DRS	DRS	→
4/10/25	EFFECT	EFFECT	→
2/18/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/18/25	SCHEDULE 13G	SCHEDULE 13G	→
↓

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(492 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
10/28/25	DEFA14A	DEFA14A	→
10/27/25	DEF 14A	DEF 14A	→
10/16/25	PRE 14A	PRE 14A	→
11/5/24	DEFA14A	DEFA14A	→
11/5/24	DEF 14A	DEF 14A	→
10/23/24	PRE 14A	PRE 14A	→
↓

Filed	Form	Description
12/29/25	4	4	→
12/29/25	4	4	→
9/10/25	3	3	→
9/4/25	4	4	→
9/4/25	3	3	→
9/4/25	3	3	→
↓